Get the Stockscreener App
3.80
0.26%
0.010
After Hours:
3.73
-0.07
-1.84%
Cingulate Inc stock is traded at $3.80, with a volume of 177.31K.
It is up +0.26% in the last 24 hours and down -9.09% over the past month.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
See More
Previous Close:
$3.79
Open:
$3.74
24h Volume:
177.31K
Relative Volume:
0.96
Market Cap:
$20.57M
Revenue:
-
Net Income/Loss:
$-21.21M
P/E Ratio:
-0.1166
EPS:
-32.6
Net Cash Flow:
$-16.86M
1W Performance:
+1.06%
1M Performance:
-9.09%
6M Performance:
-12.04%
1Y Performance:
-1.30%
1-Day Range:
$3.636
$3.83
1-Week Range:
$3.52
$3.85
52-Week Range:
$3.02
$6.01
Cingulate Inc Stock (CING) Company Profile
Name
Cingulate Inc
Sector
Industry
Phone
(913) 942-2300
Address
1901 W. 47TH PLACE, KANSAS CITY
Compare CING with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
3.80 | 21.25M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | ROTH MKM | Buy |
| Dec-22-23 | Downgrade | Laidlaw | Buy → Hold |
Cingulate Inc Stock (CING) Latest News
Trend analysis for Cingulate Inc. Equity Warrant this weekBond Market & Long-Term Safe Investment Plans - newser.com
What data driven models say about Cingulate Inc.’s futureJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Signal strength of Cingulate Inc. stock in tech scannersJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Will Cingulate Inc. Equity Warrant stock recover faster than market2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
Will Cingulate Inc. Equity Warrant stock deliver long term returns2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Combining price and volume data for Cingulate Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Cingulate Inc. stock ready for a breakoutWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Can Cingulate Inc. stock deliver consistent earnings growthWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Why Cingulate Inc. stock remains on watchlists2025 Price Targets & Low Risk Entry Point Tips - newser.com
Will Cingulate Inc. Equity Warrant stock pay special dividendsWeekly Profit Report & Growth Focused Entry Reports - newser.com
Is Cingulate Inc. Equity Warrant meeting your algorithmic filter criteriaBreakout Watch & Verified Technical Trade Signals - newser.com
Measuring Cingulate Inc. Equity Warrant’s beta against major indices2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Why Cingulate Inc. stock is seen as undervaluedGold Moves & Low Risk High Reward Trade Ideas - newser.com
Will Cingulate Inc. stock beat EPS estimates2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
Why Cingulate Inc. Equity Warrant stock appeals to analystsJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Can technical indicators confirm Cingulate Inc. Equity Warrant’s reversal2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growthWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Will Cingulate Inc. stock remain a Wall Street favorite2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Will a bounce in Cingulate Inc. offer an exit2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Can Cingulate Inc. Equity Warrant stock continue upward trendPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
How supply chain issues affect Cingulate Inc. stockMarket Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Cingulate Inc. (CING) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Cingulate Inc. Equity Warrant stock supported by strong cash flowsQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
How Cingulate Inc. Equity Warrant stock trades during market volatilityWeekly Gains Summary & Long Hold Capital Preservation Plans - newser.com
Real time breakdown of Cingulate Inc. stock performanceMarket Risk Summary & Momentum Based Trading Ideas - newser.com
Operating cash flow per share of Cingulate, Inc. Warrant 2021-03.12.26 on Cingulate – NASDAQ:CINGW - TradingView
Can Cingulate Inc. stock resist market sell offsInsider Buying & Breakout Confirmation Trade Signals - newser.com
Risk adjusted return profile for Cingulate Inc. Equity Warrant analyzedJuly 2025 Levels & Risk Managed Investment Signals - newser.com
Cingulate Inc Stock (CING) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):